Rapid, noninvasive diagnosis is critical for stroke patient management. Conventional detection methods are often limited by slow turnaround and high costs. This work demonstrates a proof-of-concept, highly sensitive sensor for exhaled carbon monoxide (CO) to enable preclinical stroke monitoring in animal models. The system is based on near-infrared cavity ringdown spectroscopy (CRDS), in which birefringence noise in the high-finesse cavity is suppressed via polarization control, achieving a measurement sensitivity of 2.6 × 10 -12 cm −1 and a corresponding CO detection limit of 1.5 ppb. A novel scheme combining low-frequency large-amplitude laser current scanning for resonance acquisition, high-frequency small-amplitude dithering for continuous ring-down event recording, and stepwise PZT voltage adjustment, was developed to achieve efficient resonance locking and a tenfold improvement in spectral resolution. Additionally, a breath sampling and filtration device was designed to suppress interference from high concentrations of CO 2 and H 2 O in exhaled breath. The system enabled detection of exhaled CO in rat stroke models, providing a potential rapid and noninvasive screening approach for stroke in preclinical studies.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: